Form 4: Boston Scientific Director Edward J. Ludwig Receives Equity Award

Director Edward J. Ludwig acquired 2,081 shares of Boston Scientific common stock as an annual equity award.

Summary

• On May 8, 2025, Edward J. Ludwig, a director of Boston Scientific Corp, acquired 2,081 shares of common stock.
• The acquisition was an annual equity award.
• The shares were acquired at a price of $0.00 per share.
• Following the transaction, Ludwig directly owns 26,479 shares of Boston Scientific common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine equity award, which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The equity award aligns the director's interests with those of the shareholders.

Industry Context

Equity awards are a common form of compensation for directors of publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• The size and structure of equity awards can vary significantly based on company size, performance, and industry benchmarks.
• Comparing Boston Scientific's director compensation practices to those of its peers, such as Medtronic (MDT) and Abbott Laboratories (ABT), would provide further context.

Stakeholder Impact

• The equity award aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.

Next Steps

• The shares will vest upon the next annual meeting of stockholders.

Key Dates

Keywords

equity award, director, common stock, BSX, Boston Scientific, Form 4